+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Brachytherapy Market 2019-2025

  • PDF Icon

    Report

  • November 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4896974
UP TO OFF until Dec 31st 2022
The brachytherapy market is expected to grow with a CAGR of 3.5% during the forecast period. Brachytherapy is also known as internal radiation therapy which is used for the treatment of cancer. Brachytherapy allows doctors to supply high doses of radiation to the specific areas of the body and to the body part which is prone to cancer. Treatment or cure time from brachytherapy is usually shorter than any other form of treating cancer. Brachytherapy is the most common and widely used treatment to cure prostate cancer. It is also widely used to cure gynecologic cancers, cervical cancer, skin cancer, uterine cancer, lung cancer, rectal cancer, and eye cancer.

According to the World Health Organization (WHO), cancer is the second leading cause of annual death and more than 9.6 million death globally reported due to cancer in 2018. WHO states that 70% of cancer deaths occur from middle and low-income countries? Brachytherapy is considered the safest and efficient way to treat cancer which is acting as a driving factor for the global brachytherapy market. The continuous development of innovative technologies for cancer treatment is offering an opportunity for the global brachytherapy industry.

The global brachytherapy market is analyzed on the basis of geographical regions, including North America, Europe, Asia-Pacific, and the rest of the world (RoW). North America is growing significantly in the global brachytherapy market in 2018. This is mainly owing to the increasing cancer cases in North America and the high adoption of advanced technology for cancer treatment. Asia-Pacific is projected to exhibit the fastest growth in the global market during the forecast period. Significant rise in cancer incidences coupled with improving healthcare infrastructure in emerging economies sector such as China and India are the major factor propelling the market growth in Asia-Pacific.

Some crucial players operating in the global brachytherapy market include Elekta AB, Best Medical International, Inc., Eckert & Ziegler BEBIG, AngioDynamics, Inc. and Varian Medical Systems, Inc. Geographical expansion, merger & acquisition, partnerships & collaborations, finding a new market or advancing their core competency to expand individual market share are some of the key strategies adopted by major market players. For instance, in January 2018, IsoRay, Inc. signed an exclusive manufacturing and supply agreement with GT Medical Technologies, Inc. for brachytherapy product, GammaTile Radiation Therapy System. This is an important step of IsoRay, Inc. for the commercialization of GammaTile products.

Research Methodology

The market study of the global brachytherapy market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog

The report is intended for the medical device manufacturers, suppliers, and distributors, government and investment agencies for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Brachytherapy Market Research and Analysis by Indication
2. Global Brachytherapy Market Research and Analysis by Type

The Report covers:
  • Comprehensive research methodology of the global brachytherapy market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global brachytherapy market.
  • Insights about market determinants which are stimulating the global brachytherapy market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Elekta AB
3.3.1.1. Overview
3.3.1.2. SWOT Analysis
3.3.1.3. Recent Developments
3.3.2. Best Medical International, Inc.
3.3.2.1. Overview
3.3.2.2. SWOT Analysis
3.3.2.3. Recent Developments
3.3.3. Eckert & Ziegler BEBIG
3.3.3.1. Overview
3.3.3.2. SWOT Analysis
3.3.3.3. Recent Developments
3.3.5. Varian Medical Systems, Inc.
3.3.3.4. Overview
3.3.3.5. SWOT Recent Developments
3.3.3.6. Recent Developments
3.3.4. AngioDynamics, Inc.
3.3.4.1. Overview
3.3.4.2. SWOT Analysis
3.3.4.3. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Brachytherapy Market by Indication
5.1.1. Breast Cancer
5.1.2. Gynecological Cancer
5.1.3. Prostate Cancer
5.1.4. Skin Cancer
5.1.5. Brain Cancer
5.1.6. Others
5.2. Global Brachytherapy Market by Type
5.2.1. Low-Dose Rate (LDR) Brachytherapy
5.2.2. High-Dose Rate (HDR) Brachytherapy
5.2.3. Other (Permanent Brachytherapy)
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AngioDynamics, Inc.
7.2. Best Medical International, Inc.
7.3. Boston Scientific Corp.
7.4. C. R. Bard, Inc. (Becton, Dickinson & Co.)
7.5. C4 Imaging, LLC
7.6. Carl Zeiss Meditec AG
7.7. CIVCO Medical Solutions
7.8. Eckert & Ziegler BEBIG
7.9. Elekta AB
7.10. General Electric Co.
7.11. Hologic, Inc.
7.12. iCAD, Inc.
7.13. IsoAid LLC
7.14. Isoray, Inc.
7.15. Merit Medical Systems, Inc.
7.16. Sensus Healthcare, Inc.
7.17. Sun Nuclear Corp.
7.18. Theragenics Corp.
7.19. Varian Medical Systems, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AngioDynamics, Inc.
  • Best Medical International, Inc.
  • Boston Scientific Corp.
  • C. R. Bard, Inc. (Becton, Dickinson & Co.)
  • C4 Imaging, LLC
  • Carl Zeiss Meditec AG
  • CIVCO Medical Solutions
  • Eckert & Ziegler BEBIG
  • Elekta AB
  • General Electric Co.
  • Hologic, Inc.
  • iCAD, Inc.
  • IsoAid LLC
  • Isoray, Inc.
  • Merit Medical Systems, Inc.
  • Sensus Healthcare, Inc.
  • Sun Nuclear Corp.
  • Theragenics Corp.
  • Varian Medical Systems, Inc.